Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$137.18

0.86 (0.63%)

, IBB

iShares Nasdaq Biotechnology Index

$109.77

0.04 (0.04%)

14:24
11/04/19
11/04
14:24
11/04/19
14:24

Piper says GW Pharmaceuticals shares could react well to even slight Q3 beat

Piper Jaffray analyst Danielle Brill said she thinks Q3 revenues from GW Pharmaceuticals, which reports tomorrow, should surpass her $84.8M revenue estimate and that "even a slight" beat should benefit the stock as it will increase investors' confidence that Epidiolex growth continues to be robust beyond the initial bolus effect that came with the product's launch. She also notes the stock is down 18% since the company's Q2 earnings, compared to a 5% advance for the iShares Nasdaq Biotechnology Index (IBB) over the same time. Brill keeps an Overweight rating and $210 price target on shares of GW Pharmaceuticals.

GWPH

GW Pharmaceuticals

$137.18

0.86 (0.63%)

IBB

iShares Nasdaq Biotechnology Index

$109.77

0.04 (0.04%)

  • 05

    Nov

GWPH GW Pharmaceuticals
$137.18

0.86 (0.63%)

10/14/19
LEER
10/14/19
NO CHANGE
LEER
Outperform
Investor concerns related to GW Pharmaceuticals 'misplaced,' says SVB Leerink
SVB Leerink analyst Marc Goodman notes that it has been a "tough late summer/fall" for GW Pharmaceuticals, as misplaced investor concerns have beaten up the stock significantly and Friday was no different. The analyst points out that the concern on Friday started as investors checked on the weekly Symphony Rx data for the first week of October, which indicated a significant decline from the previous week. He was able to confirm with the company that a "very significant specialty pharmacy" had stopped reporting weekly Rxs to the data providers that flow into Symphony Rx, which makes sense given the surprisingly abrupt Rx trend on Friday. Goodman still believes Epidiolex can be a "significant" product in epilepsy. He reiterates an Outperform rating on the shares.
10/21/19
NEED
10/21/19
INITIATION
Target $200
NEED
Buy
GW Pharmaceuticals initiated with a Buy at Needham
Needham analyst Serge Belanger initiated coverage of GW Pharmaceuticals with a Buy rating and $200 price target, saying its Epidiolex is on a "fast track" to a "blockbuster" drug after becoming the first FDA-approved CBD therapeutic last year. The analyst notes that thus far, Epidiolex has exceeded its early launch expectations given the "pent-up demand" and broad product awareness, along with an unmet need for treating rare pediatric disorders, adding that its blockbuster potential is highlighted by the 104% sequential increase in Q2 sales to $68.4M. Belanger adds that the recent pullback in the stock price was driven by "inaccurate" reporting of safety events and presents an attractive entry opportunity.
10/30/19
HCWC
10/30/19
INITIATION
Target $170
HCWC
Buy
GW Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao initiated coverage of GW Pharmaceuticals with a Buy rating and $170 price target. The analyst believes GW shares are positioned to move higher as quarterly results show that Epidiolex's launch can be sustained. Further, dose titration and penetration into off-label patient populations "should fuel growth and offer a bridge" to the expected label expansion into the tuberous sclerosis complex in mid-2020, Tsao tells investors in a research note.
10/30/19
10/30/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Global Payments (GPN) reinstated with an Overweight at JPMorgan. 2. Gossamer Bio (GOSS) initiated with a Buy at Berenberg. 3. Health Catalyst (HCAT) initiated with an Overweight at Cantor Fitzgerald. 4. GW Pharmaceuticals (GWPH) initiated with a Buy at H.C. Wainwright while Sage Therapeutics (SAGE) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
IBB iShares Nasdaq Biotechnology Index
$109.77

0.04 (0.04%)

TODAY'S FREE FLY STORIES

TREE

LendingTree

$293.67

-13 (-4.24%)

08:31
12/13/19
12/13
08:31
12/13/19
08:31
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$31.01

0.82 (2.72%)

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Conference/Events
Unum Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Options
One option delisting on December 13th »

Option delistings…

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

FORM

FormFactor

$24.96

1.19 (5.01%)

, INTC

Intel

$57.56

0.52 (0.91%)

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Recommendations
FormFactor, Intel, Samsung, TSMC analyst commentary  »

FormFactor price target…

FORM

FormFactor

$24.96

1.19 (5.01%)

INTC

Intel

$57.56

0.52 (0.91%)

SSNLF

Samsung

$0.00

(0.00%)

TSM

TSMC

$58.61

2.71 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 23

    Jan

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$47.44

1 (2.15%)

, FBHS

Fortune Brands

$65.51

0.31 (0.48%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Recommendations
Masco, Fortune Brands analyst commentary  »

Masco, Fortune Brands…

MAS

Masco

$47.44

1 (2.15%)

FBHS

Fortune Brands

$65.51

0.31 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$194.19

2.09 (1.09%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$88.89

0.9 (1.02%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.86

1.19 (1.99%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

0.58 (1.80%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Conference/Events
The FDA Dermatologic & Ophthalmic Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

XLY

Consumer Discretionary Sector SPDR

$123.10

1.12 (0.92%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$60.92

0.85 (1.42%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$62.86

-0.32 (-0.51%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$62.54

-0.09 (-0.14%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$100.94

0.93 (0.93%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$163.97

1.4 (0.86%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$281.94

2.23 (0.80%)

08:21
12/13/19
12/13
08:21
12/13/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$317.06

2.65 (0.84%)

08:21
12/13/19
12/13
08:21
12/13/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$30.82

0.6 (1.99%)

08:21
12/13/19
12/13
08:21
12/13/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$359.70

7.3 (2.07%)

08:21
12/13/19
12/13
08:21
12/13/19
08:21
Recommendations
Tesla analyst commentary  »

Global demand for Teslas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

SMH

Market Vectors Semiconductor

$140.37

3.99 (2.93%)

08:20
12/13/19
12/13
08:20
12/13/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$206.52

1.54 (0.75%)

08:20
12/13/19
12/13
08:20
12/13/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.